Latest Articles

Publication Date
FOXA2 sensitizes endometrial carcinoma to progestin-mediated conservative therapy by triggering PR transcriptional activation - Nature

FOXA2 sensitizes endometrial carcinoma to progestin-mediated conservative therapy by triggering PR transcriptional activation Nature

Published: Sept. 13, 2025, 5:58 a.m.
Severe endometriosis complicated by deep vein thrombosis and pulmonary embolism in the absence of hormone therapy: A case report and literature review.

To report a rare case of severe endometriosis complicated by deep vein thrombosis (DVT) and pulmonary embolism (PE) without hormone exposure, and review similar cases in the literature.

Published: Sept. 13, 2025, midnight
Identification of Adeno-Associate Virus (AAV) Serotype for Endometriosis Therapy and Effect of AAV-Mediated RNAi Delivery on Gene Expression and Cell Proliferation in In Vitro Endometrial Cell Culture.

Endometriosis is a chronic estrogen-dependent condition with limited treatment options, often requiring surgery and long-term hormonal therapy that may impair ovarian function. Despite advancements in gene therapy for other diseases, …

Published: Sept. 13, 2025, midnight
Helixor A enhances natural killer cell activity by induction of PAI-1 expression through the p38/MAPK signaling pathway.

Helixor A, an anticancer drug, has an immunostimulatory effect that increases T and natural killer (NK) cell activity in patients with cancer and endometriosis. However, the molecular mechanisms underlying its …

Published: Sept. 12, 2025, midnight
Understanding Endometriosis: A Broad Review of Its Causes, Management, and Impact.

Endometriosis is a complex gynecological condition affecting 10% of women globally, characterized by the growth of endometrial-like tissue outside the uterus, leading to chronic pelvic pain, infertility, reduced quality of …

Published: Sept. 12, 2025, midnight
Efficacy of Elagolix and Relugolix for the Treatment of Pelvic Pain in Patients With Endometriosis: A Systematic Review.

Endometriosis is a chronic gynecological condition commonly associated with pelvic pain, dysmenorrhea, dyspareunia, and infertility. Owing to the limitations and adverse effects of traditional hormonal therapies, this study aimed to …

Published: Sept. 12, 2025, midnight
Specialty Influences Postcancer Hormone Therapy Prescribing - Medscape

Specialty Influences Postcancer Hormone Therapy Prescribing Medscape

Published: Sept. 11, 2025, 1:07 p.m.
Cartherics wins APAC Award for most promising iPSC therapy pipeline - Biotech Dispatch

Cartherics wins APAC Award for most promising iPSC therapy pipeline Biotech Dispatch

Published: Sept. 11, 2025, 12:46 a.m.
Impact of endometrioma management strategies on ovarian reserve over the follow-up period, a prospective longitudinal study.

The effects of current treatment options for endometrioma on ovarian reserve remain controversial. Recent advancements in surgical techniques may challenge the previously established evidence regarding the detrimental effects of surgery …

Published: Sept. 11, 2025, midnight
Endometrial cancer drug Rina-S wins FDA's breakthrough therapy designation - Rare Cancer News

Endometrial cancer drug Rina-S wins FDA's breakthrough therapy designation Rare Cancer News

Published: Sept. 10, 2025, 12:49 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!